about
Cytochrome P450 isoform selectivity in human hepatic theobromine metabolismAnimal models of human response to dioxinsMetabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic aminesCyp1a2(-/-) null mutant mice develop normally but show deficient drug metabolismA practical strategy to design and develop an isoform-specific fluorescent probe for a target enzyme: CYP1A1 as a case study.Molecular epidemiology: recent advances and future directions.Determination of ipriflavone in human plasma by LC-MS and its application in a pharmacokinetic study.Inhibition of baicalin on metabolism of phenacetin, a probe of CYP1A2, in human liver microsomes and in rats.Cytochrome P4501A2 phenotype and bladder cancer risk: The Shanghai bladder cancer study.Pathway-Targeted Pharmacogenomics of CYP1A2 in Human Liver.Physiologically based pharmacokinetic (PBPK) modeling of caffeine and theophylline in neonates and adults: implications for assessing children's risks from environmental agents.Transient gene delivery for functional enrichment of differentiating embryonic stem cells.Effects of CYP2B6 and CYP1A2 Genetic Variation on Nevirapine Plasma Concentration and Pharmacodynamics as Measured by CD4 Cell Count in Zimbabwean HIV-Infected Patients.Enhanced expression of cytochrome P450 in stomach cancer.Alternative splicing within the human cytochrome P450 superfamily with an emphasis on the brain: The convolution continues.Cytochrome P450 1A1 genetic polymorphisms and risk of hepatocellular carcinoma among chronic hepatitis B carriers.Interindividual variability of methadone response: impact of genetic polymorphism.Gene expression and immunochemical localization of major cytochrome P450 drug-metabolizing enzymes in bovine nasal olfactory and respiratory mucosa.Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms.DNA sequence variation in a 3.7-kb noncoding sequence 5' of the CYP1A2 gene: implications for human population history and natural selection.Mitochondrial targeting of cytochrome P450 (CYP) 1B1 and its role in polycyclic aromatic hydrocarbon-induced mitochondrial dysfunction.In vitro analysis of factors influencing CYP1A2 expression as potential determinants of interindividual variation.Chemical inhibitors of cytochrome P450 isoforms in human liver microsomes: a re-evaluation of P450 isoform selectivity.Pharmacogenetics of olanzapine metabolism.Characterization of cytochrome P450s mediating ipriflavone metabolism in human liver microsomes.Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins.In vitro assessment of human cytochrome P450.Cytochrome P450 knockout mice: new toxicological models.Interactions of chemical carcinogens and genetic variation in hepatocellular carcinoma.Effects of benzimidazole derivatives on cytochrome P450 1A1 expression in a human hepatoma cell line.Genetic variation in the CYP1A1 gene is related to circulating PCB118 levels in a population-based sample.CYP polymorphisms and pathological conditions related to chronic exposure to organochlorine pesticides.Human and rat primary hepatocyte CYP1A1 and 1A2 induction with 2,3,7,8-tetrachlorodibenzo-p-dioxin, 2,3,7,8-tetrachlorodibenzofuran, and 2,3,4,7,8-pentachlorodibenzofuran.Identification of human cytochrome P450 enzymes involved in the hepatic and intestinal biotransformation of 20(S)-protopanaxadiol.The impact of genetic polymorphisms on CYP1A2 activity in humans: a systematic review and meta-analysis.N-acetyl-2-aminofluorene (AAF) processing in adult rat hepatocytes in primary culture occurs by high-affinity low-velocity and low-affinity high-velocity AAF metabolite-forming systems.CYP gene family variants as potential protective factors in drug addiction in Han Chinese.Metabolite profiling and enzyme reaction phenotyping of luseogliflozin, a sodium-glucose cotransporter 2 inhibitor, in humans.In vitro metabolism of eupatilin by multiple cytochrome P450 and UDP-glucuronosyltransferase enzymes.Detection of three genetic polymorphisms in the 5'-flanking region and intron 1 of human CYP1A2 in the Japanese population.
P2860
Q24564968-662A31C3-8DE5-4FD6-8B54-49EDF1E557C8Q28390140-7B78F8BA-60DD-4804-8583-840ED812458DQ28391158-779D2DFA-0A1F-4412-B5A1-6290844C537EQ28510829-2E5C79AD-85FB-4F6B-A0EC-BD0F3779DE4DQ33662661-B4424C75-55ED-475C-815C-A52CE828706EQ33846244-2A6E0D15-DBF9-4581-9AB4-2D632A04B1BFQ33905508-EF89D320-C544-40D4-9134-F1F2035A74E3Q35108016-098F1D40-49A5-4D87-A65A-70DCD812E455Q35199390-7A64B797-2BB2-4854-9D0F-9F55F89E8D60Q35210306-F058530C-72CE-4E15-9917-67BCDBB92675Q35624622-644541CF-5974-4D35-A0C2-795EFAAB0CABQ35805133-B5EB27AA-3B22-4AC4-9718-51E45995B6F6Q36074119-83A9907A-6730-417C-BE04-BB0B4C83DB73Q36292285-8BBB940D-A840-45B8-8ABA-B8239531F2C3Q36544917-8A66EAE4-3FB0-4C13-A038-2E806A6C30AAQ36617813-942F3505-8033-42D3-883A-BE2441EF6F54Q37142009-DCEF4CAD-6C44-4CFC-99F5-96F6D3D8C9E8Q37145892-0C802CDB-4BEA-45D3-B9FB-1BA69F4F5265Q37157901-83F2503D-B954-4FCA-B547-D22CC315824DQ37218857-3783A32F-DBAD-4FDE-938C-1D6F5FE7A7A4Q37683416-8C5256CC-173A-4297-8252-83D49C17AE2AQ37724295-A7980553-4434-4056-BAA3-6F28CC2E79F2Q37845170-131C4894-FBEA-43F8-81EE-D01596379CC8Q38127716-222776C6-39A3-4134-B3A6-F553EE776AA0Q38505185-11A3485C-7A55-45C4-AFCB-8CB82103A286Q40700838-9D201F20-46DB-4C1F-98A6-3737AF761B07Q40828743-66E0FCAC-0D71-44DE-AC14-5A3A82BD4807Q40838718-A01D6DBD-835E-4967-A666-AC9C63890EF6Q41128742-A7C13EB3-004C-407E-ADC7-A9F2BDCE4357Q41141334-D1B688C5-E693-4607-9B8E-5FF9011FBBD9Q41455829-63D7EAB8-7405-498C-9DB6-C29BEBA95F5FQ41679027-B9469878-135E-497E-864A-2A3B38D2DC92Q42939000-76A16E70-8EAC-4B96-8D3F-470159E7DF42Q46690569-99C594DB-F2BD-44AE-A6A4-2DDE59788442Q49546782-53AE5AF1-CB33-4047-B719-1458972A447DQ50105379-02284944-A65E-4B9A-8511-C01105D4D37BQ51306296-87B6B56E-846E-424A-A132-71040B4AA8AAQ51679305-CB07F74F-79E6-4D9E-935F-EC69343375B3Q53564543-18C18EFE-EFB3-4633-87A2-1571CE25E3CDQ55043253-A646955D-1998-4B43-9BA6-2B8708AA822E
P2860
description
1993 nî lūn-bûn
@nan
1993 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Expression of CYP1A1 and CYP1A2 genes in human liver
@ast
Expression of CYP1A1 and CYP1A2 genes in human liver
@en
Expression of CYP1A1 and CYP1A2 genes in human liver
@nl
type
label
Expression of CYP1A1 and CYP1A2 genes in human liver
@ast
Expression of CYP1A1 and CYP1A2 genes in human liver
@en
Expression of CYP1A1 and CYP1A2 genes in human liver
@nl
prefLabel
Expression of CYP1A1 and CYP1A2 genes in human liver
@ast
Expression of CYP1A1 and CYP1A2 genes in human liver
@en
Expression of CYP1A1 and CYP1A2 genes in human liver
@nl
P2093
P1476
Expression of CYP1A1 and CYP1A2 genes in human liver
@en
P2093
D Nagorney
H Schweikl
J A Goldstein
J A Taylor
S Kitareewan
P304
P356
10.1097/00008571-199310000-00003
P407
P577
1993-10-01T00:00:00Z